Veeva Systems launches Veeva OpenKey at Eyeforpharma Barcelona 2015

Veeva Unveils a New Approach to Customer Reference Data that's Open, Easy, and Global

Ecosystem of Veeva OpenKey Partners Align to Make Using Customer Data

Seamless and Cost-Effective

On the opening day of Eyeforpharma Barcelona 2015, Veeva Systems (NYSE: VEEV) announced Veeva OpenKey, a new approach to customer reference data for the life sciences industry. Veeva OpenKey builds on Veeva's growing presence in the data business with a bold vision to provide customer data for all healthcare professionals (HCP), healthcare organisations (HCO), and affiliations across life sciences' major markets-and to do so with consistent standards for quality and service.

Veeva also announced the Veeva OpenKey Partner Program, which establishes a partner ecosystem designed to make it easy for life sciences companies to access and maximise their customer data. Today, companies' ability to fully leverage the customer data they purchase is hampered by restrictive vendor contracts that limit usage and access. With data access agreements and partnerships in place with other third-party providers, Veeva OpenKey eliminates those complications.

(Logo: http://photos.prnewswire.com/prnh/20120425/527164 )

"Veeva is dedicated to solving the customer data challenges for life sciences organisations, with a customer-first approach to quality and service," said Tim Slevin, senior vice president of Veeva's global data solutions business. "This starts with freeing companies of the constraints preventing them from reaping the full benefits of their customer data and our commitment to deliver an offering that provides truly global support."

Survey Reveals Need for Data That is Open, Easy, and Global

Currently, 83 percent of life sciences executives surveyed report the quality of their customer data is a significant challenge, according to preliminary results of the Veeva 2015 European Life Sciences Industry Survey on Customer Data. More than one in four say they are dissatisfied with the service they receive from their current data provider, and just 12 percent say incumbent providers have innovated to deliver high-quality data solutions.

Veeva OpenKey will provide a faster, more responsive service with a consistently high standard for quality across regions. Veeva OpenKey will make it easy for companies to use the data they need-wherever, whenever, and however they need it, without the burdensome contractual restrictions that exist in the customer data market today. And its fair, simple pricing is free of complicated conditions or surprises.

In the face of changing regulations and more stringent reporting requirements, the need for consistent, cross-border customer data has never been more acute. Less than a year away from the January 2016 European Federation of Pharmaceutical Industries and Associations' (EFPIA) payment disclosure deadline, only 39 percent of companies surveyed definitively report that their customer data allows them to accurately track or aggregate spend at the HCP level. And only 29 percent have data that fully allows them to manage HCP engagement activity across regional or country borders.

To eliminate the burden of managing multiple data feeds and duplication of HCP and HCO records across European markets Veeva OpenKey Customer Data will be sourced locally and consolidated into a single global reference database.

"Life sciences companies struggle to maintain timely, complete customer data across their internal systems, resulting in significant compliance and customer engagement challenges," said Eric Newmark, program director, Business Systems Strategies for IDC Health Insights. "Much of the challenge stems from their inability to integrate and fully utilise the data they purchase today. More open access to quality data and partner ecosystems that work together to ensure access is seamless for customers is something the industry desperately needs."

"We are proud to partner with Veeva as they continue their journey towards a vision of providing the most comprehensive data and service solutions for the life sciences industry," said Robert Bryant, Partner at Deloitte. "We have worked with Veeva on early Veeva OpenKey customers and have been impressed with the solution and vision."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mpox clade Ib transmitted in a healthcare setting outside Africa